Literature DB >> 20061827

Monoclonal antibody to dengue capsid protein: its application in dengue studies.

Y Vazquez1, Maritza Pupo-Antúnez, S V Vazquez, V Capó, G Torres, Y Caballero, A Sánchez, D Limonta, M Alvarez, M G Guzmán.   

Abstract

Dengue fever (DF) and dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) are considered the most important arthropod-borne viral diseases in terms of morbidity and mortality. The emergency and severity of dengue (Den) infections increase the necessity of an early, quick and effective dengue laboratory diagnostic. Viral isolation is considered a gold standard for diagnosis of dengue infection using monoclonal antibodies (mAbs) as a tool for determining serotype specificity. Alternatives have been used to improve sensitivity and time to dengue diagnosis. Based on the early expression of dengue C protein in the life cycle, we focused our study on the application of an anti-dengue 2 virus capsid protein mAb in dengue diagnosis. The kinetic expression of dengue-2 capsid in mosquito cells and its immuno-localization in experimentally infected suckling albin Swiss (OF-1) mice brain tissues was established. The results demonstrate the possible utility of this mAb in early dengue diagnosis versus traditional isolation. In addition, a preliminary study of an enzyme immunoassay method using 8H8 mAb for specific detection of dengue C protein antigen was performed, making possible recombinant C protein quantification. The results suggest that detection of dengue capsid protein could be useful in the diagnosis of early dengue infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20061827      PMCID: PMC2725423          DOI: 10.4161/mabs.1.2.7908

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  47 in total

Review 1.  Dengue diagnosis, advances and challenges.

Authors:  María G Guzmán; Gustavo Kourí
Journal:  Int J Infect Dis       Date:  2004-03       Impact factor: 3.623

2.  Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections.

Authors:  Pei-Yun Shu; Li-Kuang Chen; Shu-Fen Chang; Yi-Yun Yueh; Ling Chow; Li-Jung Chien; Chuan Chin; Ting-Hsiang Lin; Jyh-Hsiung Huang
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

3.  New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA.

Authors:  Tatsuji Kimura; Akinori Rokuhara; Akihiro Matsumoto; Shintaro Yagi; Eiji Tanaka; Kendo Kiyosawa; Noboru Maki
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

4.  Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization.

Authors:  Kala Jessie; Mun Yik Fong; Shamala Devi; Sai Kit Lam; K Thong Wong
Journal:  J Infect Dis       Date:  2004-04-05       Impact factor: 5.226

5.  Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies.

Authors:  Wayne R Hogrefe; Ronald Moore; Mary Lape-Nixon; Michael Wagner; Harry E Prince
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

6.  Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence.

Authors:  E A Henchal; M K Gentry; J M McCown; W E Brandt
Journal:  Am J Trop Med Hyg       Date:  1982-07       Impact factor: 2.345

7.  Laboratory diagnosis of primary and secondary dengue infection.

Authors:  Stefan Schilling; Diana Ludolfs; Le Van An; Herbert Schmitz
Journal:  J Clin Virol       Date:  2004-11       Impact factor: 3.168

8.  Detection of immune-complex-dissociated nonstructural-1 antigen in patients with acute dengue virus infections.

Authors:  Penelopie Koraka; Chantal P Burghoorn-Maas; Andrew Falconar; Tatty E Setiati; Kiss Djamiatun; Jan Groen; Albert D M E Osterhaus
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

9.  Dengue virus infection of mice: morphology and morphogenesis of dengue type-2 virus in suckling mouse neurones.

Authors:  S Sriurairatna; N Bhamarapravati; O Phalavadhtana
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

10.  Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway.

Authors:  Joo-Sung Yang; Mathura P Ramanathan; Karuppiah Muthumani; Andrew Y Choo; Sung-Ha Jin; Qian-Chun Yu; Daniel S Hwang; Daniel K Choo; Mark D Lee; Kesen Dang; Waixing Tang; J Joseph Kim; David B Weiner
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more
  4 in total

Review 1.  Rapid Detection Strategies for the Global Threat of Zika Virus: Current State, New Hypotheses, and Limitations.

Authors:  Shruti Shukla; Sung-Yong Hong; Soo Hyun Chung; Myunghee Kim
Journal:  Front Microbiol       Date:  2016-10-24       Impact factor: 5.640

2.  Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay.

Authors:  Ferdinard Adungo; Fuxun Yu; David Kamau; Shingo Inoue; Daisuke Hayasaka; Guillermo Posadas-Herrera; Rosemary Sang; Matilu Mwau; Kouichi Morita
Journal:  Clin Vaccine Immunol       Date:  2016-08-05

3.  Modification of S-Adenosyl-l-Homocysteine as Inhibitor of Nonstructural Protein 5 Methyltransferase Dengue Virus Through Molecular Docking and Molecular Dynamics Simulation.

Authors:  Usman Sumo Friend Tambunan; Mochammad Arfin Fardiansyah Nasution; Fauziah Azhima; Arli Aditya Parikesit; Erwin Prasetya Toepak; Syarifuddin Idrus; Djati Kerami
Journal:  Drug Target Insights       Date:  2017-04-20

4.  Natural antibody responses to the capsid protein in sera of Dengue infected patients from Sri Lanka.

Authors:  Mahesha N Nadugala; Chandima Jeewandara; Gathsaurie N Malavige; Prasad H Premaratne; Charitha L Goonasekara
Journal:  PLoS One       Date:  2017-06-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.